1. Home
  2. MDXH vs STHO Comparison

MDXH vs STHO Comparison

Compare MDXH & STHO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXH
  • STHO
  • Stock Information
  • Founded
  • MDXH 2003
  • STHO N/A
  • Country
  • MDXH Belgium
  • STHO United States
  • Employees
  • MDXH N/A
  • STHO N/A
  • Industry
  • MDXH
  • STHO Real Estate
  • Sector
  • MDXH
  • STHO Real Estate
  • Exchange
  • MDXH Nasdaq
  • STHO Nasdaq
  • Market Cap
  • MDXH 84.6M
  • STHO 89.7M
  • IPO Year
  • MDXH 2021
  • STHO N/A
  • Fundamental
  • Price
  • MDXH $2.09
  • STHO $6.59
  • Analyst Decision
  • MDXH Buy
  • STHO
  • Analyst Count
  • MDXH 1
  • STHO 0
  • Target Price
  • MDXH $6.00
  • STHO N/A
  • AVG Volume (30 Days)
  • MDXH 75.5K
  • STHO 94.3K
  • Earning Date
  • MDXH 05-14-2025
  • STHO 05-12-2025
  • Dividend Yield
  • MDXH N/A
  • STHO N/A
  • EPS Growth
  • MDXH N/A
  • STHO N/A
  • EPS
  • MDXH N/A
  • STHO N/A
  • Revenue
  • MDXH $94,507,000.00
  • STHO $113,297,000.00
  • Revenue This Year
  • MDXH $23.38
  • STHO N/A
  • Revenue Next Year
  • MDXH $16.84
  • STHO N/A
  • P/E Ratio
  • MDXH N/A
  • STHO N/A
  • Revenue Growth
  • MDXH 25.46
  • STHO N/A
  • 52 Week Low
  • MDXH $1.35
  • STHO $6.09
  • 52 Week High
  • MDXH $3.50
  • STHO $14.50
  • Technical
  • Relative Strength Index (RSI)
  • MDXH 74.52
  • STHO 37.98
  • Support Level
  • MDXH $1.67
  • STHO $6.33
  • Resistance Level
  • MDXH $1.99
  • STHO $6.79
  • Average True Range (ATR)
  • MDXH 0.13
  • STHO 0.38
  • MACD
  • MDXH 0.02
  • STHO 0.03
  • Stochastic Oscillator
  • MDXH 97.67
  • STHO 19.89

About MDXH MDxHealth SA

MDxHealth SA is a multinational healthcare company that provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. Its tests are based on proprietary genomic, epigenetic, and other molecular technologies and assist physicians with the diagnosis of urologic cancers, the prognosis of recurrence risk, and the prediction of response to a specific therapy. It derives revenues from clinical laboratory service testing or the out-licensing of the company's patented DNA methylation platform and biomarkers. Geographically, it derives revenue from the United States of America (USA) and Europe.

About STHO Star Holdings Shares of Beneficial Interest

Star Holdings engages in non-ground lease-related businesses, including real estate finance, operating properties, and land and development. Its portfolio is comprised of its interests in Asbury and Magnolia Green residential development projects, a portfolio of commercial real estate properties, and loans that are being marketed for sale. The Company operates its business through one reportable and operating segment that focuses on realizing value for shareholders by generating cash flows through active asset management and sales of its existing loans, operating properties and land and development properties.

Share on Social Networks: